Literature DB >> 32569299

Ubiquitin activation is essential for schizont maturation in Plasmodium falciparum blood-stage development.

Judith L Green1, Yang Wu1, Vesela Encheva2, Edwin Lasonder3, Adchara Prommaban1,4, Simone Kunzelmann5, Evangelos Christodoulou5, Munira Grainger1, Ngoc Truongvan6, Sebastian Bothe7, Vikram Sharma3, Wei Song8, Irene Pinzuti8, Chairat Uthaipibull9, Somdet Srichairatanakool4, Veronique Birault10, Gordon Langsley11, Hermann Schindelin6, Benjamin Stieglitz8, Ambrosius P Snijders2, Anthony A Holder1.   

Abstract

Ubiquitylation is a common post translational modification of eukaryotic proteins and in the human malaria parasite, Plasmodium falciparum (Pf) overall ubiquitylation increases in the transition from intracellular schizont to extracellular merozoite stages in the asexual blood stage cycle. Here, we identify specific ubiquitylation sites of protein substrates in three intraerythrocytic parasite stages and extracellular merozoites; a total of 1464 sites in 546 proteins were identified (data available via ProteomeXchange with identifier PXD014998). 469 ubiquitylated proteins were identified in merozoites compared with only 160 in the preceding intracellular schizont stage, suggesting a large increase in protein ubiquitylation associated with merozoite maturation. Following merozoite invasion of erythrocytes, few ubiquitylated proteins were detected in the first intracellular ring stage but as parasites matured through trophozoite to schizont stages the apparent extent of ubiquitylation increased. We identified commonly used ubiquitylation motifs and groups of ubiquitylated proteins in specific areas of cellular function, for example merozoite pellicle proteins involved in erythrocyte invasion, exported proteins, and histones. To investigate the importance of ubiquitylation we screened ubiquitin pathway inhibitors in a parasite growth assay and identified the ubiquitin activating enzyme (UBA1 or E1) inhibitor MLN7243 (TAK-243) to be particularly effective. This small molecule was shown to be a potent inhibitor of recombinant PfUBA1, and a structural homology model of MLN7243 bound to the parasite enzyme highlights avenues for the development of P. falciparum specific inhibitors. We created a genetically modified parasite with a rapamycin-inducible functional deletion of uba1; addition of either MLN7243 or rapamycin to the recombinant parasite line resulted in the same phenotype, with parasite development blocked at the schizont stage. Nuclear division and formation of intracellular structures was interrupted. These results indicate that the intracellular target of MLN7243 is UBA1, and this activity is essential for the final differentiation of schizonts to merozoites.

Entities:  

Year:  2020        PMID: 32569299     DOI: 10.1371/journal.ppat.1008640

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  10 in total

1.  Stochastic expression of invasion genes in Plasmodium falciparum schizonts.

Authors:  Jaishree Tripathi; Lei Zhu; Sourav Nayak; Michal Stoklasa; Zbynek Bozdech
Journal:  Nat Commun       Date:  2022-05-30       Impact factor: 17.694

Review 2.  cAMP-Dependent Signaling Pathways as Potential Targets for Inhibition of Plasmodium falciparum Blood Stages.

Authors:  Edwin Lasonder; Kunal More; Shailja Singh; Malak Haidar; Daniela Bertinetti; Eileen J Kennedy; Friedrich W Herberg; Anthony A Holder; Gordon Langsley; Chetan E Chitnis
Journal:  Front Microbiol       Date:  2021-05-24       Impact factor: 5.640

Review 3.  Histone Modification Landscapes as a Roadmap for Malaria Parasite Development.

Authors:  J Connacher; H von Grüning; L Birkholtz
Journal:  Front Cell Dev Biol       Date:  2022-04-01

Review 4.  Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases.

Authors:  Marie-José Bijlmakers
Journal:  Front Chem       Date:  2021-01-28       Impact factor: 5.221

5.  Deletion of Plasmodium falciparum ubc13 increases parasite sensitivity to the mutagen, methyl methanesulfonate and dihydroartemisinin.

Authors:  Supawadee Maneekesorn; Ellen Knuepfer; Judith L Green; Parichat Prommana; Chairat Uthaipibull; Somdet Srichairatanakool; Anthony A Holder
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.996

Review 6.  Targeting the Plasmodium falciparum proteome and organelles for potential antimalarial drug candidates.

Authors:  James Abugri; Joseph Ayariga; Samuel Sunyazi Sunwiale; Cletus Adiyaga Wezena; Julien Agyemang Gyamfi; Michael Adu-Frimpong; Godfred Agongo; Julius Tieroyaare Dongdem; Daniel Abugri; Bismarck Dinko
Journal:  Heliyon       Date:  2022-08-24

Review 7.  Targeting SUMOylation in Plasmodium as a Potential Target for Malaria Therapy.

Authors:  Daffiny Sumam de Oliveira; Thales Kronenberger; Giuseppe Palmisano; Carsten Wrenger; Edmarcia Elisa de Souza
Journal:  Front Cell Infect Microbiol       Date:  2021-06-10       Impact factor: 5.293

Review 8.  Ubiquitin-Like Modifiers: Emerging Regulators of Protozoan Parasites.

Authors:  Maryia Karpiyevich; Katerina Artavanis-Tsakonas
Journal:  Biomolecules       Date:  2020-10-03

9.  Repurposing the Pathogen Box compounds for identification of potent anti-malarials against blood stages of Plasmodium falciparum with PfUCHL3 inhibitory activity.

Authors:  Hina Bharti; Aakriti Singal; Manisha Saini; Pradeep Singh Cheema; Mohsin Raza; Suman Kundu; Alo Nag
Journal:  Sci Rep       Date:  2022-01-18       Impact factor: 4.379

10.  Beyond phosphorylation: Putative roles of post-translational modifications in Plasmodium sexual stages.

Authors:  Nila Johnson; Nisha Philip
Journal:  Mol Biochem Parasitol       Date:  2021-07-27       Impact factor: 1.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.